BSECompany Update22h ago · 30 Oct 2026, 07:03 pm
Intimation of Cyber Security Incident
Windlas Biotech Ltd · 543329
✦ AI SummaryRegulatory
Windlas Biotech Ltd has experienced a cyber security incident on October 30, 2026, but it does not have any material impact on the company's core business operations, financial performance, or business continuity.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk6/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Windlas Biotech Ltd - 543329 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015- Intimation Of Cyber Security Incident
Attachments (1)
📄pdf
Download →
b8b3ba1d-fd92-4c08-959a-491ca0f9d413.pdf
View document text
Windlas Biotech Limited
Reg. Off.: 40/1, Mohabewala Industrial Area
Dehradun, Uttarakhand 248 110, India
Tel.:+91-135-6608000-30, Fax:+91-135-6608199
Corp. Off.: 705-706, Vatika Professional Point, Sector-66,
Golf Course Ext. Road, Gurgaon, Haryana 122 001, India
Tel.:+91-124-2821030
CIN-L74899UR2001PLC033407
October 30, 2026
To To
Listing / Compliance Department Listing / Compliance Department
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G
Dalal Street, Mumbai – 400 001 Bandra Kurla Complex
Bandra (E), Mumbai – 400 051
BSE CODE: 543329 NSE SYMBOL: WINDLAS
Dear Sir/ Madam,
Subject: Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015- Intimation of Cyber Security Incident
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015, we hereby inform you that the Company has experienced a cyber security incident on
October 30, 2026.
We wish to submit that this does not have any material impact on the Company’s core business operations, financial
performance or business continuity. A detailed assessment is currently underway and appropriate remedial and preventive
measures are being implemented as required.
This disclosure is being made as a matter of good governance.
This is for your kind information and record.
Thanking you,
Yours faithfully,
For Windlas Biotech Limited
Ananta Narayan Panda
Company Secretary & Compliance Officer
www.windlas.com